Back to top
more

West Pharmaceutical Services (WST)

(Real Time Quote from BATS)

$323.98 USD

323.98
412,055

+9.21 (2.93%)

Updated Nov 5, 2024 02:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks News

PRA Health (PRAH) Enters Into Strategic Deal With Deep Lens

PRA Health's (PRAH) deal with Deep Lens can help detect and match oncology patients to suitable clinical trials and best precision therapies.

Here's Why You Should Retain Cooper Companies (COO) Stock

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

Top Ranked Growth Stocks to Buy for September 18th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 18th.

Is West Pharmaceutical Services (WST) Stock Outpacing Its Medical Peers This Year?

Is (WST) Outperforming Other Medical Stocks This Year?

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

Here's Why You Should Invest in AMN Healthcare (AMN) Stock

AMN Healthcare (AMN) continues to gain traction from its wide range of services, and Healthcare MSP.

Varian (VAR) Expands Presence With Germany's Ethos Order

Varian's (VAR) Ethos therapy is being adopted in Germany, thus expanding the company's geographic footprint.

Here's Why You Should Retain AmerisourceBergen Stock Now

AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches. However, stiff competition remains a woe.

Cerner (CERN) Inks Deal With Finland Regional Leadership

Cerner (CERN) collaborates with Finland regional leadership to help bring integrated health and care.

Varian Expands Access to Advanced Cancer Treatment With Ethos

Varian's (VAR) Ethos Therapy used by Goshen Center for Cancer Care marks the expansion access to personalized cancer care.

PRA Health (PRAH) Inks Deal With Leukemia & Lymphoma Society

PRA Health (PRAH) partners with LLS to bring new treatments for children with relapsed acute leukemia.

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

Nevro (NVRO) continues to gain traction from Senza, its flagship platform, and R&D capabilities. However, stiff competition remains a woe.

Varian's Halcyon System to Bring Improved Care to Singapore

Varian (VAR) strengthens its partnership Proton Therapy Pte as it brings improved care to Singapore through Halcyon system.

NextGen Healthcare Introduces New Behavioral Health Suite

NextGen Healthcare's (NXGN) new behavioral health suite aims to provide whole person care with support services for healthcare providers and clinicians.

Cooper Companies (COO) Q3 Earnings & Revenues Top Estimates

Cooper Companies' (COO) fiscal third-quarter earnings reflect dismal segmental performance. However, it exceeded expectation as it witnessed faster-than-anticipated recovery.

Top Ranked Growth Stocks to Buy for September 4th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, September 4th.

Aurora Cannabis (ACB) to Post Q4 Earnings: What's in Store?

Aurora Cannabis' (ACB) fiscal fourth-quarter results likely to reflect solid prospects in the Canadian market.

Patterson Companies (PDCO) Q1 Earnings Top Estimates, Up Y/Y

Despite weak performance across Patterson Companies' (PDCO) Dental and Animal Health segments in the fiscal first quarter results, it benefited from aggressive cost savings measures.

Zacks.com featured highlights include: Kinsale Capital, American States Water, Gibraltar Industries, D.R. Horton and West Pharmaceutical

Zacks.com featured highlights include: Kinsale Capital, American States Water, Gibraltar Industries, D.R. Horton and West Pharmaceutical

Aparajita Dutta headshot

Buy These 5 Low Leverage Stocks Amid Ongoing Economic Crisis

As the global economy is still topsy turvy, thanks to the coronavirus pandemic, investors should be even more careful while choosing stocks

What's in Store for Patterson Companies' (PDCO) Q1 Earnings?

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect sluggishness at Dental segment.

Here's Why You Should Invest in LHC Group (LHCG) Stock Now

LHC Group (LHCG) continues to gain traction from its broad range of services, and strategic acquisitions and joint ventures.

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

Cooper Companies' (COO) fiscal third-quarter performance is likely to reflect weak performance by CVI and CSI.

Is West Pharmaceutical Services (WST) Outperforming Other Medical Stocks This Year?

Is (WST) Outperforming Other Medical Stocks This Year?

Hologic Updates Breast Biopsy System to Enhance Workflow

Hologic (HOLX) introduces features to update Brevera Breast Biopsy System in order to transform patient experience and enhance workflow.